Instil Bio (TIL) Earnings Analysis
Instil Bio (TIL) next reports earnings on 2026-08-12, consensus EPS -0.35 USD. Last quarter (2026-05-15) it beat with EPS -0.62 USD vs -0.62 USD est (0%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -1.02.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TIL next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.35 USD |
| Revenue estimate | n/a |
TIL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.62 USD | -0.62 USD | 0% | Beat |
| 2026-03-27 | -1.21 USD | -2.31 USD | +47.6% | Beat |
| 2025-11-13 | -2.01 USD | -2 USD | -0.5% | Miss |
| 2025-08-13 | -3.24 USD | -1.72 USD | -88.4% | Miss |
| 2025-03-04 | -1.82 USD | -3.75 USD | +51.5% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
TIL valuation and analyst view
| Trailing P/E | -1.02 |
|---|---|
| Trailing EPS | -6.98557 USD |
| Price / book | 0.44 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Hold (2 buy / 6 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is Instil Bio (TIL)'s next earnings date?
Instil Bio is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.35 USD.
Did TIL beat earnings last quarter?
In its 2026-05-15 report, TIL posted EPS of -0.62 USD versus a -0.62 USD estimate — a beat of 0%.
What is TIL's earnings track record?
Over the last 5 reported quarters with consensus data, TIL beat estimates 3 times (60%).
What is TIL's current P/E ratio and EPS?
TIL trades at a trailing P/E of -1.02 on trailing EPS of -6.985574705661005 USD.
What do analysts rate TIL?
Analyst consensus is "Hold" across 8 ratings (0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.